Oprima aquí para acceder al blog en español. Gloria A. lives in Puerto Rico. She is a passionate advocate, professional engineer, and friend to many people in the lung cancer community. She is an avid supporter of the Atlanta Braves [...]
When people think about treatment options after receiving a lung cancer diagnosis, they often don’t think about clinical trials. In fact, many people are fearful of exploring clinical trials and may shy away from discussing them with their care [...]
Question: My dad’s doctor recommended a liquid biopsy in addition to a tissue biopsy when he was diagnosed because the liquid biopsy would be faster. Why is this important? (Answered by Dr. Mohana Roy from the Stanford Department of [...]
We are delighted to welcome Sarah McHale, LCSW, OSW-C, to the GO2 Patient Support Team as senior manager of support programs and implementation. Sarah joins Maureen Rigney, Miranda Goff, and Michele Zeh on GO2’s HelpLine to offer one-on-one support, [...]
Terry G. lives in Plainfield, IL, where she likes to ride her motorcycle, play water volleyball, and make fused glass art pieces. My diagnosis In October 2003, when I was 41 years old, I needed to see a doctor [...]
Healthcare delivery not only impacts your experiences at your health care center but can also affect your treatment outcomes. Processes and procedures are put in place at health care facilities to attempt to standardize and regulate things like wait [...]
Question: I was diagnosed with early-stage lung cancer. Do I need biomarker testing? Can I benefit from a targeted therapy if a biomarker is discovered? (Answered by Dr. Collin Blakely from the University of California, San Francisco, during his [...]
Jim Fackler lives in Lancaster, South Carolina, with his wife, Gail. He is a proud Vietnam veteran who served in the United States Navy. He enjoys golf, driving his pontoon on the lake, home improvement projects, and meeting [...]
For people diagnosed with late-stage lung cancer, Edward “Buddy” Cutler’s story may serve as a beacon of hope, a clinical trial success story, and a reminder that statistics don’t dictate a person’s unique experience. When Buddy was diagnosed with [...]
Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer The first anti-cancer therapy, mechlorethamine, was approved in 1949. Since then, the U.S. Food and Drug Administration (FDA) has worked to ensure that new lifesaving [...]